Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Quetiapine: quite the contender in bipolar disorders

    • 12 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Ekman M, Lindgren P, Miltenburger C, Meier G, Locklear JC, Chatterton ML.Cost-effectiveness of quetiapine in patients with acute bipolar depression and in maintenance treatment after an acute depressive episode. 162nd Annual Meeting of the American Psychiatric Association: 151 abstr. NR4-045, 19 May 2009. Available from: URL: http://www.psych.org

    2. 2.

      Tafesse E, Lazarus A.The cost-effectiveness of quetiapine as an adjunct to a mood stabilizer in the maintenance treatment of bipolar I disorder. 162nd Annual Meeting of the American Psychiatric Association: 175 abstr. NR4-107, 19 May 2009. Available from: URL: http://www.psych.org

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Quetiapine: quite the contender in bipolar disorders. Pharmacoecon. Outcomes News 581, 1 (2009). https://doi.org/10.2165/00151234-200905810-00001

    Download citation

    Keywords

    • Bipolar Disorder
    • Olanzapine
    • Lamotrigine
    • Quetiapine
    • Aripiprazole